Fundraising Fox

Neuroptics

Irvine, US · Founded 1995 · 83 employees on LinkedIn · 1 known investors

NeurOptics manufactures the NPi-300 pupillometer, a handheld medical device that measures pupil size and reactivity for critical care assessment in hospitals. The device serves neurologists, critical care specialists, and nurses in intensive care units managing neurologically ill patients.

HealthtechMedical Devices

Founders & leadership

KS
Kamran SiminouExecutive
WW
William WorthenExecutive
JK
Joseph KianiNamed on SEC filing
WW
Willam WorthenNamed on SEC filing

Board

BM
Bob MellenBoard director

Investors · 1

Aphelion Capital

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 3 rounds · 2014–2016

▶$500KraisedApr 2016 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kamran SiminouExecutive Officer, Director
  • Bob MellenDirector
  • Joseph KianiDirector
  • William WorthenExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
Proceeds to insiders
$25K
First sale
Apr 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedSep 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kamran SiminouExecutive Officer, Director
  • Joseph KianiDirector
  • William WorthenExecutive Officer, Director
  • Bob MellenDirector
Offering amount
$600K
Amount sold
$50K
Proceeds to insiders
$60K
First sale
Aug 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedApr 2014 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kamran SiminouExecutive Officer, Director
  • Willam WorthenExecutive Officer, Director
  • Joseph KianiDirector
Offering amount
$2.5M
Amount sold
$1.2M
Minimum investment
$1
Proceeds to insiders
$125K
First sale
Mar 2014
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Medscape53 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Neuroptics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1.3M
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$319.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Neuroptics do?
NeurOptics manufactures the NPi-300 pupillometer, a handheld medical device that measures pupil size and reactivity for critical care assessment in hospitals. The device serves neurologists, critical care specialists, and nurses in intensive care units managing neurologically ill patients.
Who are Neuroptics's investors?
Neuroptics's investors include Aphelion Capital.
How much funding has Neuroptics raised?
Neuroptics has disclosed $1.8M raised across 3 rounds.
Where is Neuroptics headquartered?
Neuroptics is headquartered in Irvine, US.